Forgot your password?

Forgot your username?

Functional Neuromodulation Biotech Specialty Pharma

200 Front Street West
Suite 3004, P.O. Box 31, Ontario M5V 3K2 Canada
Click for website
Research Sector Biotech Specialty Pharma
Summary Description Deep brain stimulation for Alzheimer's

Click here for Financial Data Keywordsdeep brain stimulation, Alzheimer's, cognitive disorders


Functional Neuromodulation Ltd. is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with Alzheimer’s and other memory and cognitive ......view more

Technology / Differentiation

Functional Neuromodulation applies deep brain stimulation (DBS) therapies to treat patients with Alzheimer?s disease (AD) as well as other memory and cognitive disorders. DBS uses an implanted medic...view more

Market / Customers

$10.2 billion market for AD in 2012. Market projected to decline to $9.5 billion by 2017, CAGR of -1.5%.2. Estimated $203 billion in direct costs of caring for AD patients in the US in 2013.......view more

Competitors / Substitutes / Alternatives

Medtronic created the DBS market, and Boston Scientific and St. Jude Medical have since entered. These companies use DBS to treat essential tremor, advanced Parkinson's disease, chronic intractable pr...view more